These interventions may reduce hypoglycemia symptoms by inducing gluconeogenesis, reducing insulin secretion, or mitigating the initial hyperglycemic peak, which mainly treats the symptom, but not the cause. The gene discussed is INS; the disease is Hypoglycemia.